Invex Therapeutics (ASX:IXC) Dividend Yield % : 0.00% (As of Apr. 01, 2025)

View and export this data going back to 2019. Start your Free Trial

What is Invex Therapeutics Dividend Yield %?

As of today (2025-04-01), the Trailing Annual Dividend Yield of Invex Therapeutics is 0.00%.

The historical rank and industry rank for Invex Therapeutics's Dividend Yield % or its related term are showing as below:

ASX:IXC's Dividend Yield % is not ranked ^*
in the Biotechnology industry.
Industry Median: 1.45
* Ranked among companies with meaningful Dividend Yield % only.

Invex Therapeutics's Dividend Payout Ratio for the six months ended in Dec. 2024 was 0.00.

During the past 5 years, the highest Dividend Payout Ratio of Invex Therapeutics was 186.00. The lowest was 0.00. And the median was 0.00.

As of today (2025-04-01), the Forward Dividend Yield % of Invex Therapeutics is 0.00%.

Invex Therapeutics's Dividends per Share for the six months ended in Dec. 2024 was A$0.00.

During the past 12 months, Invex Therapeutics's average Dividends Per Share Growth Rate was -100.00% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.

Invex Therapeutics Dividend Yield % Historical Data

The historical data trend for Invex Therapeutics's Dividend Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Invex Therapeutics Dividend Yield % Chart

Invex Therapeutics Annual Data

Trend

Jun20

Jun21

Jun22

Jun23

Jun24

Dividend Yield %

310.50

Invex Therapeutics Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Dividend Yield %	Get a 7-Day Free Trial						-	-	230.00	310.50	282.27

Competitive Comparison of Invex Therapeutics's Dividend Yield %

For the Biotechnology subindustry, Invex Therapeutics's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Invex Therapeutics's Dividend Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Invex Therapeutics's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Invex Therapeutics's Dividend Yield % falls into.

Save Embed

;

Save Embed

;

Invex Therapeutics Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

Invex Therapeutics (ASX:IXC) Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.

Invex Therapeutics Dividend Yield % Related Terms

Thank you for viewing the detailed overview of Invex Therapeutics's Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Invex Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Invex Therapeutics Ltd (ASX:IXC) » Definitions » Dividend Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

38 Rowland Street, Level 1, Subiaco, WA, AUS, 6008

Website

https://www.invextherapeutics.com

Invex Therapeutics Ltd is a biopharmaceutical company, focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of neurological conditions derived from or involving raised ICP including TBI, stroke and hydrocephalus. In addition, the Group has generated early-stage data on the use of Exenatide in the treatment of glaucoma, through the lowering of intraocular pressure in the eye. Geographically, it operates only in Australia.